News Special: Controlling Dermal Filler Regulation

Published

Written by...

Share this article

Within the aesthetics specialty, regulation and patient safety has remained a continuous debate. However, with the recent Health and Care Bill 2022 being implemented by the government to introduce a licensing scheme for practitioners operating in England, it seems that regulation within the industry is slowly starting to progress.1
In a recently published document, the Medicines and Healthcare products Regulatory Agency (MHRA) outlined the government’s response to a consultation on the future regulation of medical devices in the UK.2 The consultation took place between September and November 2021 with 891 responses involving 263 healthcare professionals and 200 manufacturers of medical devices, as well as involvement from healthcare institutions, enterprises, members of the public and trade associations.
According to the document, the biggest support was on improving patient safety from the Government and the MHRA aims to prepare regulations to ensure this remains a priority. These include…

Subscriber content

Continue reading this clinical article

To read this post in full you need an Aesthetics Journal subscription. Choose the plan that fits your practice — every paid plan includes the complete peer-reviewed clinical library and CPD-accredited learning.